A checklist you can use inside the consultation room
Quick answer
Before agreeing to a stem cell kidney programme, work through twelve questions: legal status of the product, cell source, GMP standards, dose and number of sessions, outcome measures, adverse-event handling, total cost and the follow-up plan after you fly home. Vague answers are reason enough to wait.
First cluster, the product: what exactly is it, where is it manufactured, under which Korean legal framework is it permitted, and can you see batch documentation? These four alone filter out most opaque providers.
Second cluster, the plan: dose per session, number of sessions, intervals, outcome measures, and what happens if renal markers do not improve. A clearly defined stopping rule signals professionalism.
Third cluster, safety and money: known adverse events and their management, who is responsible if something goes wrong, what the all-in cost covers, and how follow-up with a doctor in Thailand will work after you return.
Treat it as a warning sign and postpone the decision.
Yes — medical and contractual details affect both understanding and patient rights.
Only with written refund terms, including the case where cell culture fails.
Strongly yes, ideally from a nephrologist with no stake in the programme.
How results are measured and when to stop — it forces everyone to talk about real outcomes.
5 points • reviewed 2026-09-02
Reviewed and last updated: 2026-09-02
5 sources • every claim is traceable
https://www.ehlbio.co.kr
https://www.mfds.go.kr/eng/index.do
https://www.mohw.go.kr/eng/
https://pubmed.ncbi.nlm.nih.gov/
https://www.medicalkorea.or.kr/
Last updated: 2026-09-02 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories